by MM360 Staff | Feb 4, 2026 | Myeloma News
Source: Pharmacy Times articles Post Content Read More
by MM360 Staff | Feb 4, 2026 | Uncategorized
Source: CURE articles Post Content Read More
by MM360 Staff | Feb 4, 2026 | Uncategorized
Source: CURE articles Post Content Read More
by Marisa Wexler, MS | Feb 3, 2026 | Myeloma News
A treatment regimen combining Darzalex Faspro (daratumumab and hyaluronidase-fihj) with three other medications is now approved in the U.S. for all people newly diagnosed with multiple myeloma. The combination treatment, known as D-VRd, uses Darzalex Faspro alongside...
by MM360 Staff | Feb 3, 2026 | Publications
Br J Haematol. 2026 Feb 1. doi: 10.1111/bjh.70356. Online ahead of print. NO ABSTRACT PMID:41622574 | DOI:10.1111/bjh.70356